Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children

Micturition Reeductation in Children With Cerebral Palsy: Uroflow/EMG Measurement in Healthy Children

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03339609

Enrollment

Registered

2017-11-13

Start date

2014-09-30

Completion date

2017-06-30

Last updated

2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Urinary Tract Symptoms, Urologic Diseases

Brief summary

Nowadays there is a growing interest towards non-invasive assessment of urinary dysfunctions in clinical practice. The tendency to use uroflowmetry as a first-line screening tool is based on the inexpensiveness, time efficiency, comfort of the patient, etc. However, it is stated that uroflowmetry as a stand-alone study lacks the potential to make an accurate diagnosis. In regard to this, the International Continence Society indicated that the addition of pelvic floor electromyography might increase the accuracy of this assessment. Despite this recommendation, uroflowmetry in combination with electromyography has not been conducted in a healthy population. The initial objective of this study was to examine whether adding electromyography to standard uroflowmetry in a healthy paediatric population would change the representation of parameters, especially of voiding patterns. In addition, the influence of several factors on uroflow parameters was analysed to complement current literature.

Interventions

DIAGNOSTIC_TESTUS

Ultrasound of post void residual urine

DIAGNOSTIC_TESTUroflow

Isolated uroflow measurement

DIAGNOSTIC_TESTUroflow/EMG

Uroflow measurement with superficial EMG testing of the pelvic floor

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

5 Years to 12 Years

Healthy volunteers

Yes

Inclusion criteria

• Normal development

Exclusion criteria

* (Recurrent) urinary tract infections * LUTS which interfered with daily life * Fecal incontinence * History of genitourinary or renal surgery * Medication for incontinence during the last 3 months * Pelvic reeducation during the last 6 months * Neurologic problems influencing continence

Design outcomes

Primary

Measure	Time frame	Description
Uroflow curve pattern - Clinical assessment	2017	Interpretation by pediatric urologist
Uroflow curve pattern - Mathematical assessment	2017	Interpretation using Flow index methodology

Secondary

Measure	Time frame	Description
post-void residual urine	2017	millilitres
voiding time	2017	seconds
voided volume	2017	millilitres
Maximal flow	2017	Qmax (millilitres/seconds)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026